Correlation Between Le Travenues and Aarti Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Le Travenues and Aarti Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Le Travenues and Aarti Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Le Travenues Technology and Aarti Drugs Limited, you can compare the effects of market volatilities on Le Travenues and Aarti Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Le Travenues with a short position of Aarti Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Le Travenues and Aarti Drugs.

Diversification Opportunities for Le Travenues and Aarti Drugs

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between IXIGO and Aarti is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Le Travenues Technology and Aarti Drugs Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aarti Drugs Limited and Le Travenues is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Le Travenues Technology are associated (or correlated) with Aarti Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aarti Drugs Limited has no effect on the direction of Le Travenues i.e., Le Travenues and Aarti Drugs go up and down completely randomly.

Pair Corralation between Le Travenues and Aarti Drugs

Assuming the 90 days trading horizon Le Travenues Technology is expected to under-perform the Aarti Drugs. In addition to that, Le Travenues is 1.62 times more volatile than Aarti Drugs Limited. It trades about -0.04 of its total potential returns per unit of risk. Aarti Drugs Limited is currently generating about -0.02 per unit of volatility. If you would invest  48,860  in Aarti Drugs Limited on August 30, 2024 and sell it today you would lose (3,020) from holding Aarti Drugs Limited or give up 6.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy91.94%
ValuesDaily Returns

Le Travenues Technology  vs.  Aarti Drugs Limited

 Performance 
       Timeline  
Le Travenues Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Le Travenues Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Aarti Drugs Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aarti Drugs Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Le Travenues and Aarti Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Le Travenues and Aarti Drugs

The main advantage of trading using opposite Le Travenues and Aarti Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Le Travenues position performs unexpectedly, Aarti Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aarti Drugs will offset losses from the drop in Aarti Drugs' long position.
The idea behind Le Travenues Technology and Aarti Drugs Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios